Organism name | Rhodiola rosea L. |
---|---|
Genus | Rhodiola |
Family | Crassulaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Rhodiola rosea |
---|---|
Linked NCBI taxonomy ID | 203015 |
Linked level | species |
Family in NCBI taxonomy | Crassulaceae |
---|---|
ID | 3781 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | eudicotyledons |
---|---|
ID | 71240 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00031186
![]() |
Rosin
/ Rosin X / (-)-Rosin / trans-Cinnamyl beta-D-glucopyranoside |
No. 45 | No. 72 |
![]() |
||||
C00031274
![]() |
Salidroside
/ Rhodioloside / (-)-Rhodioloside / Tyrosol alpha-(beta-D-glucopyranoside) |
CHEMBL465208
CHEMBL1899113 |
C009172
|
3 / 0 / 0 | No. 45 | No. 72 |
![]() |
|
C00002707
![]() |
Picein
/ 4-Hydroxyacetophenone 4-glucoside |
CHEMBL1512620
|
C050880
|
3 / 0 / 0 | No. 45 | No. 72 |
![]() |
|
C00031184
![]() |
Rosarin
|
No. 128 | No. 72 |
![]() |
||||
C00031185
![]() |
Rosavin
|
CHEMBL1083511
|
1 / 1 / 1 | No. 128 | No. 72 |
![]() |
||
C00030479
![]() |
Hexadecanoic acid
/ n-Hexadecanoic acid |
CHEMBL82293
|
D019308
|
16 / 8 / 8 | 35 / 1 | No. 184 | No. 68 |
![]() |
C00000805
![]() |
alpha-Pinene
|
CHEMBL442565
|
C005451
|
3 / 3 / 2 | 0 / 1 | No. 476 | No. 35 |
![]() |
C00037531
![]() |
Myrtenol
|
CHEMBL443408
|
No. 476 | No. 35 |
![]() |
|||
C00000829
![]() |
trans-Pinocarveol
|
No. 476 | No. 35 |
![]() |
||||
C00000816
![]() |
beta-Pinene
|
CHEMBL501351
|
C010789
|
No. 476 | No. 35 |
![]() |
||
C00003110
![]() |
Caryophyllene
/ (E)-Caryophyllene / beta-Caryophyllene / (-)-(E)-Caryophyllene / (E)-beta-Caryophyllene |
CHEMBL445740
CHEMBL448700 |
2 / 3 / 7 | No. 478 | No. 38 |
![]() |
||
C00034818
![]() |
cis-Linalool oxide
|
CHEMBL29660
CHEMBL282731 CHEMBL63592 CHEMBL397730 |
14 / 17 / 50 | No. 518 | No. 6 |
![]() |
||
C00037576
![]() |
Octadecyl acetate
|
No. 793 |
![]() |
|||||
C00000823
![]() |
Limonene
|
CHEMBL15799
CHEMBL449062 |
C008281
|
7 / 21 / 48 | 6 / 6 | No. 848 | No. 35 |
![]() |
C00003050
![]() |
Perilla aldehyde
/ (R)-(+)-Perillaldehyde |
CHEMBL442913
CHEMBL469537 |
C033342
|
2 / 1 / 0 | 9 / 0 | No. 848 | No. 35 |
![]() |
C00030100
![]() |
Decanol
/ 1-Decanol / n-Decanol |
CHEMBL25363
|
C029383
|
1 / 0 / 0 | 1 / 0 | No. 877 |
![]() |
|
C00030152
![]() |
Dodecanol
/ 1-Dodecanol |
CHEMBL24722
|
D007851
|
No. 877 |
![]() |
|||
C00035115
![]() |
Benzenepropanol
/ 3-Phenylpropanol / Hydrocinnamic alcohol |
CHEMBL1606391
|
C016655
|
3 / 1 / 4 | No. 885 |
![]() |
||
C00002663
![]() |
2-Phenylethanol
/ Phenethyl alcohol / Phenylethyl alcohol / beta-Phenethyl alcohol |
CHEMBL448500
|
D010626
|
2 / 1 / 1 | No. 885 |
![]() |
||
C00003047
![]() |
Linalool
/ (R)-linalool / (R)-(-)-3,7-Dimethyl-1,6-octadien-3-ol |
CHEMBL25306
CHEMBL235672 |
C018584
|
6 / 8 / 2 | 35 / 4 | No. 958 | No. 34 |
![]() |
C00000156
![]() |
Carvacrol
|
CHEMBL281202
|
C073316
|
10 / 6 / 1 | 4 / 2 | No. 969 | No. 35 |
![]() |
C00000155
![]() |
Thymol
|
CHEMBL29411
|
D013943
|
9 / 17 / 14 | 12 / 0 | No. 969 | No. 35 |
![]() |
C00029674
![]() |
alpha-Terpineol
|
CHEMBL447597
CHEMBL449810 |
C016775
|
3 / 16 / 11 | No. 983 | No. 35 |
![]() |
|
C00001228
![]() |
Myristic acid
/ Tetradecanoic acid / n-Tetradecanoic acid |
CHEMBL111077
|
D019814
|
17 / 9 / 10 | 3 / 0 | No. 1141 | No. 68 |
![]() |
C00001231
![]() |
Caprylic acid
/ Octanoic acid / n-Octanoic acid |
CHEMBL324846
|
C031492
|
10 / 14 / 13 | 2 / 1 | No. 1141 | No. 68 |
![]() |
C00001213
![]() |
Capric acid
/ Decanoic acid / n-Decanoic acid |
CHEMBL107498
|
C031071
|
8 / 11 / 6 | 4 / 0 | No. 1141 | No. 68 |
![]() |
C00001221
![]() |
Lauric acid
/ Docosanoic acid / n-Dodecanoic acid |
CHEMBL108766
|
C030358
|
19 / 25 / 14 | 11 / 0 | No. 1141 | No. 68 |
![]() |
C00000836
![]() |
cis-Thujone
/ (+)-Thujone / beta-Thujone |
CHEMBL1444078
|
2 / 3 / 2 | No. 1161 | No. 35 |
![]() |
||
C00037338
![]() |
Isopinocamphone
|
No. 1161 | No. 35 |
![]() |
||||
C00011067
![]() |
Tricyclene
/ Teresantanane |
No. 1225 |
![]() |
|||||
C00035341
![]() |
Menthone
|
CHEMBL276311
CHEMBL1719455 |
C019466
|
1 / 0 / 0 | 3 / 0 | No. 1288 | No. 35 |
![]() |
C00037333
![]() |
Isomenthone
|
CHEMBL276311
CHEMBL1719455 |
1 / 0 / 0 | No. 1288 | No. 35 |
![]() |
||
C00031258
![]() |
Sabinene
/ 4(10)-Thujene |
CHEMBL452687
|
C035127
|
No. 1343 | No. 35 |
![]() |
||
C00000814
![]() |
(-)-trans-Carveol
|
CHEMBL1385229
CHEMBL1907992 CHEMBL1908058 |
6 / 15 / 40 | No. 1555 | No. 35 |
![]() |
||
C00037652
![]() |
Pinocarvone
|
No. 1561 | No. 35 |
![]() |
||||
C00003036
![]() |
Neral
/ Citral Z |
CHEMBL1080997
|
6 / 7 / 9 | No. 1575 | No. 34 |
![]() |
||
C00000845
![]() |
Geraniol
|
CHEMBL25719
CHEMBL452683 |
96 / 41 / 41 | No. 1575 | No. 34 |
![]() |
||
C00000855
![]() |
Nerol
/ cis-Geraniol |
CHEMBL25719
CHEMBL452683 |
96 / 41 / 41 | No. 1575 | No. 34 |
![]() |
||
C00000843
![]() |
cis-beta-Ocimene
|
No. 1698 | No. 34 |
![]() |
||||
C00035062
![]() |
Carvone
|
CHEMBL15676
CHEMBL501949 |
C006923
|
8 / 9 / 9 | 5 / 2 | No. 1740 | No. 35 |
![]() |
C00030830
![]() |
Nonanol
/ n-Nonanol |
CHEMBL24563
|
C014713
|
1 / 0 | No. 1749 |
![]() |
||
C00001264
![]() |
Octanol
/ n-Octanol / 1-Octanol / Octan-1-ol |
CHEMBL26215
|
D020003
|
5 / 6 / 5 | 2 / 0 | No. 1749 |
![]() |
|
C00010872
![]() |
beta-Phellandrene
/ (+/-)-beta-Phellandrene |
CHEMBL444254
|
C058582
|
No. 1898 | No. 35 |
![]() |
||
C00030828
![]() |
Nonanal
/ n-Nonanal |
C008664
|
1 / 1 | No. 1993 |
![]() |
|||
C00030804
![]() |
n-Decanal
|
C021170
|
2 / 0 | No. 1993 |
![]() |
|||
C00029331
![]() |
(E)-2-Nonenal
/ trans-2-Nonenal |
CHEMBL450072
|
1 / 0 / 0 | No. 2140 |
![]() |
|||
C00003040
![]() |
p-Cymene
|
CHEMBL442915
|
C007210
|
No. 2172 | No. 35 |
![]() |
||
C00032864
![]() |
Cumin alcohol
/ Cuminyl alcohol / p-Isopropylbenzyl alcohol |
No. 2172 | No. 35 |
![]() |
||||
C00000853
![]() |
Myrcene
|
CHEMBL455491
|
C008574
|
3 / 3 / 3 | No. 2285 | No. 34 |
![]() |
|
C00019221
![]() |
Benzyl benzoate
|
CHEMBL1239
|
C006723
|
12 / 5 / 8 | 3 / 2 | No. 2308 |
![]() |
|
C00002725
![]() |
Cinnamaldehyde
|
CHEMBL293492
|
C012843
|
98 / 49 / 42 | 151 / 23 | No. 2320 | No. 6 |
![]() |
C00037855
![]() |
Styrene
|
CHEMBL285235
|
D020058
|
5 / 6 / 4 | 27 / 9 | No. 2320 | No. 6 |
![]() |
C00003029
![]() |
Camphene
|
CHEMBL506889
CHEMBL510535 |
C019286
|
No. 2460 | No. 35 |
![]() |
||
C00003061
![]() |
gamma-Terpinene
/ 1-Methyl-4-(1-methylethyl)-1,4-cyclohexadiene |
CHEMBL449693
|
C018669
|
No. 2468 | No. 35 |
![]() |
||
C00003060
![]() |
alpha-Terpinene
|
No. 2468 | No. 35 |
![]() |
||||
C00036387
![]() |
1,4-p-Menthadien-7-ol
|
No. 2468 | No. 35 |
![]() |
||||
C00000839
![]() |
3-Carene
|
CHEMBL506854
|
C030218
|
No. 2690 | No. 35 |
![]() |
||
C00036969
![]() |
Cuminyl acetate
|
No. 3288 | No. 35 |
![]() |
||||
C00035072
![]() |
Cinnamyl acetate
|
No. 3509 |
![]() |
|||||
C00000357
![]() |
Hexanal
|
CHEMBL280331
|
C010463
|
7 / 0 | No. 3593 |
![]() |
||
C00000358
![]() |
n-Hexanol
|
CHEMBL14085
|
C036260
|
3 / 6 / 3 | No. 3722 |
![]() |
||
C00035784
![]() |
1-Pentanol
/ n-Pentanol |
CHEMBL14568
|
C024999
|
2 / 7 / 5 | 2 / 0 | No. 3722 |
![]() |
|
C00000861
![]() |
Terpinolene
|
CHEMBL454697
|
C027009
|
1 / 0 | No. 3725 |
![]() |
||
C00003039
![]() |
Cuminaldehyde
/ Cuminyl aldehyde / 4-Isopropyl benzaldehyde |
CHEMBL161577
|
C007165
|
2 / 4 / 2 | No. 3751 | No. 35 |
![]() |
|
C00002740
![]() |
Estragol
/ Esdragol / Estragole |
CHEMBL470671
|
C007633
|
10 / 16 / 43 | 3 / 5 | No. 3933 | No. 6 |
![]() |
C00029844
![]() |
Bornyl acetate
|
CHEMBL1439452
|
C071528
|
4 / 1 / 4 | No. 4140 | No. 35 |
![]() |
|
C00037789
![]() |
Santene
|
No. 4737 |
![]() |
|||||
C00034775
![]() |
6-Methyl-5-hepten-2-one
|
CHEMBL46340
|
C029750
|
No. 5297 |
![]() |
|||
C00034989
![]() |
(E)-Ocimene
/ trans-Ocimene |
No. 6181 |
![]() |
|||||
C00034452
![]() |
Benzaldehyde
|
CHEMBL15972
|
C032175
|
8 / 7 / 3 | 3 / 1 | No. 6311 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000358 C00000805 C00000814 C00000836 C00000853 C00001213 C00001221 C00001231 C00002740 C00037855 | 3 / 2 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001221 C00001231 C00001264 C00002725 C00002740 C00003036 C00034452 C00035062 C00037855 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000845 C00000853 C00000855 C00001213 C00001231 C00001264 C00002725 C00030479 C00037855 | 0 / 1 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000836 C00001221 C00001228 C00001264 C00002707 C00002740 C00003047 C00019221 C00031274 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00000358 C00000823 C00001221 C00001264 C00003036 C00003047 C00035062 C00037855 | 3 / 1 |
O75496 | Geminin | Unclassified protein | C00001213 C00001228 C00001231 C00002663 C00002707 C00002725 C00030479 C00031274 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00000845 C00000853 C00000855 C00001221 C00001228 C00019221 C00030100 C00030479 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000155 C00000156 C00000814 C00001213 C00001221 C00003047 C00029674 | 3 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002740 C00003036 C00019221 C00029844 C00034818 C00035115 | 0 / 1 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000805 C00001213 C00001221 C00002725 C00034818 C00035062 | 0 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002740 C00003036 C00019221 C00029844 C00034818 C00035115 | 1 / 4 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000358 C00000823 C00002725 C00019221 C00035062 C00037855 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000845 C00000855 C00001221 C00002725 C00030479 C00034452 | 1 / 1 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00000155 C00000156 C00000845 C00000855 C00003047 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000155 C00000156 C00000814 C00003047 C00029674 | 5 / 1 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00000156 C00001213 C00001221 C00001228 C00001231 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000845 C00000855 C00003110 C00019221 C00035062 | 1 / 2 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000155 C00000823 C00000845 C00000855 C00002725 | 0 / 3 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00000156 C00001213 C00001221 C00001228 C00001231 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000156 C00000845 C00000855 C00002725 C00031274 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000155 C00000823 C00001231 C00002725 C00029674 | 11 / 10 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000845 C00000855 C00002740 C00003047 C00034818 | 0 / 0 |
O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00000155 C00000156 C00002725 C00003050 | 1 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000845 C00000855 C00002725 C00034818 | 0 / 1 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00000823 C00000845 C00000855 C00034452 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00001221 C00002725 C00034452 C00034818 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001228 C00029844 C00035341 C00037333 | 0 / 0 |
O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00003036 C00003039 C00003050 C00029331 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000845 C00000855 C00002725 C00002740 | 0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000845 C00000855 C00001221 C00002725 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000845 C00000855 C00002725 C00034452 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001228 C00002663 C00019221 C00034818 | 1 / 1 |
O00255 | Menin | Unclassified protein | C00000845 C00000855 C00003110 C00035062 | 2 / 5 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00000814 C00000823 C00002740 C00034818 | 7 / 37 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000845 C00000855 C00002725 C00019221 | 1 / 1 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000805 C00000845 C00000855 C00002725 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00001221 C00003036 C00030479 C00035784 | 3 / 4 |
P03956 | Interstitial collagenase | M10A | C00000845 C00000855 C00002725 | 0 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000845 C00000855 C00002725 | 1 / 1 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000845 C00000855 C00002725 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000845 C00000855 C00002725 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000845 C00000855 C00002725 | 0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000845 C00000855 C00002725 | 1 / 8 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000845 C00000855 C00001228 | 2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000845 C00000855 C00002725 | 2 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000845 C00000855 C00002725 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000845 C00000855 C00002725 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000845 C00000855 C00002725 | 1 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000845 C00000855 C00002725 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000845 C00000855 C00002725 | 1 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000845 C00000855 C00002725 | 1 / 1 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000845 C00000855 C00002725 | 0 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000845 C00000855 C00002725 | 1 / 2 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000845 C00000855 C00002725 | 1 / 1 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000845 C00000855 C00002725 | 1 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000155 C00000156 C00000814 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000845 C00000855 C00002725 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000845 C00000855 C00002725 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000845 C00000855 C00002725 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000845 C00000855 C00002725 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000845 C00000855 C00002725 | 2 / 2 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000845 C00000855 C00002725 | 1 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000845 C00000855 C00002725 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000845 C00000855 C00002725 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000845 C00000855 C00002725 | 1 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000845 C00000855 C00002725 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000845 C00000855 C00002725 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001221 C00029844 C00035115 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000845 C00000855 C00002725 | 1 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000845 C00000855 C00002725 | 1 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000845 C00000855 C00002725 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000845 C00000855 C00002725 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000845 C00000855 C00002725 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000845 C00000855 C00002725 | 2 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000845 C00000855 C00002725 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000845 C00000855 C00002725 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00000845 C00000855 C00002725 | 2 / 1 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000845 C00000855 C00002725 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000845 C00000855 C00002725 | 2 / 2 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000845 C00000855 C00002725 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000845 C00000855 C00002725 | 1 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000845 C00000855 C00002725 | 1 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000845 C00000855 C00002725 | 2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000845 C00000855 C00002725 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000845 C00000855 C00002725 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001264 C00034818 | 3 / 3 |
O60603 | Toll-like receptor 2 | Membrane receptor | C00001228 C00030479 | 1 / 1 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002740 C00035784 | 4 / 1 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002725 C00031185 | 1 / 1 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00001228 C00030479 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00001213 C00001221 | 5 / 3 |
P14679 | Tyrosinase | Oxidoreductase | C00003039 C00034452 | 4 / 2 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001228 C00030479 | 2 / 2 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00019221 C00030479 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00000823 C00001221 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000155 C00000156 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001221 C00001228 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00000155 C00000156 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001228 C00035062 | 1 / 1 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00034818 | 1 / 2 |
P12104 | Fatty acid-binding protein, intestinal | Other cytosolic protein | C00030479 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001221 | 7 / 3 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00001231 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00034452 | 2 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00001228 | 0 / 0 |
P14902 | Indoleamine 2,3-dioxygenase 1 | Enzyme | C00034452 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00019221 | 0 / 0 |
Q9UGP5 | DNA polymerase lambda | Enzyme | C00001221 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001228 | 2 / 2 |
Q4U2R8 | Solute carrier family 22 member 6 | Antiporter | C00001231 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001228 | 0 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | C00030479 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00030479 | 1 / 0 |
P40925 | Malate dehydrogenase, cytoplasmic | Enzyme | C00019221 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00000814 | 0 / 0 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00034818 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00002740 | 2 / 0 |
P30556 | Type-1 angiotensin II receptor | Angiotensin receptor | C00019221 | 1 / 1 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00030479 | 0 / 0 |
P05413 | Fatty acid-binding protein, heart | Other cytosolic protein | C00030479 | 0 / 0 |
Q05193 | Dynamin-1 | Structural | C00001228 | 0 / 0 |
O00167 | Eyes absent homolog 2 | Enzyme | C00002707 | 0 / 0 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | C00034818 | 3 / 3 |
P15090 | Fatty acid-binding protein, adipocyte | Other cytosolic protein | C00030479 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002725 | 1 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00035062 | 2 / 0 |
Q01469 | Fatty acid-binding protein, epidermal | Other cytosolic protein | C00030479 | 0 / 0 |
P51692 | Signal transducer and activator of transcription 5B | Unclassified protein | C00034818 | 1 / 1 |
Q9NSA0 | Solute carrier family 22 member 11 | Transporter | C00001231 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00034818 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001221
C00002725
C00003050
C00030479
C00037855 |
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000155
C00000823
C00002725
C00030479
C00037855 |
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00001213
C00001221
C00001231
C00001264
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000155
C00000156
C00002725
C00030479
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000155
C00002725
C00030479
C00037855
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000357
C00000823
C00002725
C00003047
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000861
C00002725
C00003047
C00030479
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001213
C00001221
C00001228
C00030479
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00001221
C00001228
C00001231
C00030479
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00002725
C00003047
C00037855
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00001221
C00002740
C00037855
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00000357
C00002725
C00003047
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000823
C00003047
C00037855
|
217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00000357
C00030804
C00034452
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000357
C00030804
C00030828
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001221
C00002725
C00030479
|
8989 | TRPA1, ANKTM1, FEPS | transient receptor potential cation channel, subfamily A, member 1 |
C00000156
C00002725
|
199974 | CYP4Z1, CYP4A20 | cytochrome P450, family 4, subfamily Z, polypeptide 1 (EC:1.14.14.1) |
C00001221
C00001228
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000823
C00002725
|
218 | ALDH3A1, ALDH3, ALDHIII | aldehyde dehydrogenase 3 family, member A1 (EC:1.2.1.5) |
C00000357
C00034452
|
221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00000357
C00034452
|
2554 | GABRA1, ECA4, EJM, EJM5 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
C00035062
C00035341
|
388 | RHOB, ARH6, ARHB, MST081, MSTP081, RHOH6 | ras homolog family member B |
C00003050
C00035062
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001264
C00030100
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00003047
C00003050
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00003047
C00030479
|
4852 | NPY, PYY4 | neuropeptide Y |
C00000823
C00003047
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002725
C00030479
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00002725
C00030479
|
1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00002725
C00003047
|
387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00003050
C00035062
|
2566 | GABRG2, CAE2, ECA2, GEFSP3 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
C00035062
C00035341
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002725
C00037855
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00002725
C00037855
|
2561 | GABRB2 | gamma-aminobutyric acid (GABA) A receptor, beta 2 |
C00035062
C00035341
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00002725
C00003047
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00002725
C00003050
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00002725
C00003047
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00002725
C00003047
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00002725
C00003047
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00001213
C00001221
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000155
C00002725
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00002725
C00030479
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00002725
C00030479
|
9817 | KEAP1, INrf2, KLHL19 | kelch-like ECH-associated protein 1 |
C00002725
C00003050
|
162514 | TRPV3, OLMS, VRL3 | transient receptor potential cation channel, subfamily V, member 3 |
C00000155
C00000156
|
3638 | INSIG1, CL-6, CL6 | insulin induced gene 1 |
C00002725
C00003047
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002725
C00003047
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00030479
C00037855
|
3251 | HPRT1, HGPRT, HPRT | hypoxanthine phosphoribosyltransferase 1 (EC:2.4.2.8) |
C00002725
C00037855
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00002725
C00037855
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00002725
C00003047
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00002725
C00037855
|
6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00030479
|
51232 | CRIM1, CRIM-1, S52 | cysteine rich transmembrane BMP regulator 1 (chordin-like) |
C00002725
|
1399 | CRKL | v-crk avian sarcoma virus CT10 oncogene homolog-like |
C00002725
|
1490 | CTGF, CCN2, HCS24, IGFBP8, NOV2 | connective tissue growth factor |
C00002725
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002725
|
1581 | CYP7A1, CP7A, CYP7, CYPVII | cytochrome P450, family 7, subfamily A, polypeptide 1 (EC:1.14.13.17) |
C00002725
|
1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00002725
|
54541 | DDIT4, Dig2, REDD-1, REDD1 | DNA-damage-inducible transcript 4 |
C00002725
|
56616 | DIABLO, DFNA64, SMAC | diablo, IAP-binding mitochondrial protein |
C00002725
|
2039 | DMTN, DMT, EPB49 | dematin actin binding protein |
C00002725
|
1789 | DNMT3B, ICF, ICF1, M.HsaIIIB | DNA (cytosine-5-)-methyltransferase 3 beta (EC:2.1.1.37) |
C00002725
|
1848 | DUSP6, HH19, MKP3, PYST1 | dual specificity phosphatase 6 (EC:3.1.3.16 3.1.3.48) |
C00002725
|
83658 | DYNLRB1, BITH, BLP, DNCL2A, DNLC2A, ROBLD1 | dynein, light chain, roadblock-type 1 |
C00002725
|
55840 | EAF2, BM040, TRAITS, U19 | ELL associated factor 2 |
C00002725
|
1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00002725
|
2034 | EPAS1, ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73 | endothelial PAS domain protein 1 |
C00002725
|
2150 | F2RL1, GPR11, PAR2 | coagulation factor II (thrombin) receptor-like 1 |
C00002725
|
2213 | FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2 | Fc fragment of IgG, low affinity IIb, receptor (CD32) |
C00002725
|
9103 | FCGR2C, CD32, CD32C, CDW32, FCG2, FCRIIC, IGFR2 | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) |
C00002725
|
2263 | FGFR2, BBDS, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25 | fibroblast growth factor receptor 2 (EC:2.7.10.1) |
C00002725
|
2330 | FMO5 | flavin containing monooxygenase 5 (EC:1.14.13.8) |
C00002725
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00002725
|
2495 | FTH1, FHC, FTH, FTHL6, PIG15, PLIF | ferritin, heavy polypeptide 1 (EC:1.16.3.1) |
C00002725
|
2535 | FZD2, Fz2, fz-2, fzE2, hFz2 | frizzled family receptor 2 |
C00002725
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00002725
|
1294 | COL7A1, EBD1, EBDCT, EBR1 | collagen, type VII, alpha 1 |
C00002725
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00002725
|
2745 | GLRX, GRX, GRX1 | glutaredoxin (thioltransferase) (EC:1.8.4.1) |
C00002725
|
2844 | GPR21 | G protein-coupled receptor 21 |
C00002725
|
2877 | GPX2, GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI, GSHPx-2 | glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) |
C00002725
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00002725
|
4848 | CNOT2, CDC36, NOT2, NOT2H | CCR4-NOT transcription complex, subunit 2 |
C00002725
|
3077 | HFE, HFE1, HH, HLA-H, MVCD7, TFQTL2 | hemochromatosis |
C00002725
|
1196 | CLK2, hCLK2 | CDC-like kinase 2 (EC:2.7.12.1) |
C00002725
|
3304 | HSPA1B, HSP70-1B, HSP70-2 | heat shock 70kDa protein 1B |
C00002725
|
10553 | HTATIP2, CC3, SDR44U1, TIP30 | HIV-1 Tat interactive protein 2, 30kDa (EC:1.1.1.-) |
C00002725
|
27429 | HTRA2, OMI, PARK13, PRSS25 | HtrA serine peptidase 2 (EC:3.4.21.108) |
C00002725
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00002725
|
3429 | IFI27, FAM14D, ISG12, ISG12A, P27 | interferon, alpha-inducible protein 27 |
C00002725
|
10964 | IFI44L, C1orf29 | interferon-induced protein 44-like |
C00002725
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00002725
|
3575 | IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA | interleukin 7 receptor |
C00002725
|
1066 | CES1, ACAT, CE-1, CEH, CES2, HMSE, HMSE1, PCE-1, REH, SES1, TGH, hCE-1 | carboxylesterase 1 (EC:3.1.1.1 3.1.1.56) |
C00002725
|
994 | CDC25B | cell division cycle 25B (EC:3.1.3.48) |
C00002725
|
22801 | ITGA11, HsT18964 | integrin, alpha 11 |
C00002725
|
942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00002725
|
3727 | JUND, AP-1 | jun D proto-oncogene |
C00002725
|
29126 | CD274, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1 | CD274 molecule |
C00002725
|
10186 | LHFP | lipoma HMGIC fusion partner (EC:3.6.5.4) |
C00002725
|
29995 | LMCD1 | LIM and cysteine-rich domains 1 |
C00002725
|
29967 | LRP12, ST7 | low density lipoprotein receptor-related protein 12 |
C00002725
|
4049 | LTA, LT, TNFB, TNFSF1 | lymphotoxin alpha |
C00002725
|
79917 | MAGIX, JM10, PDZX | MAGI family member, X-linked |
C00002725
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00002725
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002725
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00002725
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002725
|
91057 | CCDC34, NY-REN-41, RAMA3 | coiled-coil domain containing 34 |
C00002725
|
8550 | MAPKAPK5, MAPKAP-K5, MK-5, MK5, PRAK | mitogen-activated protein kinase-activated protein kinase 5 (EC:2.7.11.1) |
C00002725
|
57787 | MARK4, MARK4L, MARK4S, MARKL1, MARKL1L, PAR-1D | MAP/microtubule affinity-regulating kinase 4 (EC:2.7.11.1) |
C00002725
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00002725
|
834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00002725
|
4599 | MX1, IFI-78K, IFI78, MX, MxA | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
C00002725
|
100132406 | NBPF10, AB6, AG1, NBPF9 | neuroblastoma breakpoint family, member 10 |
C00002725
|
653361 | NCF1, NCF1A, NOXO2, SH3PXD1A, p47phox | neutrophil cytosolic factor 1 |
C00002725
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00002725
|
55973 | BCAP29, BAP29 | B-cell receptor-associated protein 29 |
C00002725
|
22981 | NINL, NLP, dJ691N24.1 | ninein-like |
C00002725
|
4854 | NOTCH3, CADASIL, CASIL, IMF2 | notch 3 |
C00002725
|
23250 | ATP11A, ATPIH, ATPIS | ATPase, class VI, type 11A (EC:3.6.3.1) |
C00002725
|
56666 | PANX2, PX2, hPANX2 | pannexin 2 |
C00002725
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00002725
|
5140 | PDE3B, HcGIP1, cGIPDE1 | phosphodiesterase 3B, cGMP-inhibited (EC:3.1.4.17) |
C00002725
|
7262 | PHLDA2, BRW1C, BWR1C, HLDA2, IPL, TSSC3 | pleckstrin homology-like domain, family A, member 2 |
C00002725
|
8544 | PIR | pirin (iron-binding nuclear protein) (EC:1.13.11.24) |
C00002725
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00002725
|
5447 | POR, CPR, CYPOR, P450R | P450 (cytochrome) oxidoreductase (EC:1.6.2.4) |
C00002725
|
8496 | PPFIBP1, L2, SGT2, hSGT2, hSgt2p | PTPRF interacting protein, binding protein 1 (liprin beta 1) |
C00002725
|
5514 | PPP1R10, CAT53, FB19, PNUTS, PP1R10, R111, p99 | protein phosphatase 1, regulatory subunit 10 |
C00002725
|
11107 | PRDM5, BCS2, PFM2 | PR domain containing 5 |
C00002725
|
57636 | ARHGAP23 | Rho GTPase activating protein 23 |
C00002725
|
57679 | ALS2, ALS2CR6, ALSJ, IAHSP, PLSJ | amyotrophic lateral sclerosis 2 (juvenile) |
C00002725
|
146760 | RTN4RL1, NGRH2, NgR3 | reticulon 4 receptor-like 1 |
C00002725
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00002725
|
6444 | SGCD, 35DAG, CMD1L, DAGD, SG-delta, SGCDP, SGD | sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
C00002725
|
6563 | SLC14A1, HUT11, HsT1341, JK, RACH1, RACH2, UT-B1, UT1, UTE | solute carrier family 14 (urea transporter), member 1 |
C00002725
|
6506 | SLC1A2, EAAT2, GLT-1 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
C00002725
|
115111 | SLC26A7, SUT2 | solute carrier family 26 (anion exchanger), member 7 |
C00002725
|
114134 | SLC2A13, HMIT | solute carrier family 2 (facilitated glucose transporter), member 13 |
C00002725
|
11046 | SLC35D2, HFRC1, SQV7L, UGTrel8, hfrc | solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 |
C00002725
|
23657 | SLC7A11, CCBR1, xCT | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
C00002725
|
6546 | SLC8A1, NCX1 | solute carrier family 8 (sodium/calcium exchanger), member 1 |
C00002725
|
4087 | SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2 | SMAD family member 2 |
C00002725
|
28966 | SNX24, PRO1284 | sorting nexin 24 |
C00002725
|
9295 | SRSF11, NET2, SFRS11, dJ677H15.2, p54 | serine/arginine-rich splicing factor 11 |
C00002725
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00002725
|
27067 | STAU2, 39K2, 39K3 | staufen double-stranded RNA binding protein 2 |
C00002725
|
8428 | STK24, MST3, MST3B, STE20, STK3 | serine/threonine kinase 24 (EC:2.7.11.1) |
C00002725
|
51684 | SUFU, PRO1280, SUFUH, SUFUXL | suppressor of fused homolog (Drosophila) |
C00002725
|
6915 | TBXA2R, BDPLT13, TXA2-R | thromboxane A2 receptor |
C00002725
|
7041 | TGFB1I1, ARA55, HIC-5, HIC5, TSC-5 | transforming growth factor beta 1 induced transcript 1 |
C00002725
|
55258 | THNSL2, SOFAT, THS2, TSH2 | threonine synthase-like 2 (S. cerevisiae) (EC:4.2.3.-) |
C00002725
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00002725
|
133 | ADM, AM | adrenomedullin |
C00002725
|
27242 | TNFRSF21, BM-018, CD358, DR6 | tumor necrosis factor receptor superfamily, member 21 |
C00002725
|
10626 | TRIM16, EBBP | tripartite motif containing 16 |
C00002725
|
132 | ADK, AK | adenosine kinase (EC:2.7.1.20) |
C00002725
|
7273 | TTN, CMD1G, CMH9, CMPD4, EOMFC, HMERF, LGMD2J, MYLK5, TMD | titin (EC:2.7.11.1) |
C00002725
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00002725
|
7321 | UBE2D1, E2(17)KB1, SFT, UBC4/5, UBCH5, UBCH5A | ubiquitin-conjugating enzyme E2D 1 (EC:6.3.2.19) |
C00002725
|
7360 | UGP2, UDPG, UDPGP, UDPGP2, UGP1, UGPP1, UGPP2, pHC379 | UDP-glucose pyrophosphorylase 2 (EC:2.7.7.9) |
C00002725
|
7374 | UNG, DGU, HIGM4, HIGM5, UDG, UNG1, UNG15, UNG2 | uracil-DNA glycosylase (EC:3.2.2.27) |
C00002725
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00002725
|
340481 | ZDHHC21, 9130404H11Rik, DHHC-21, DHHC21, DNZ1, HSPC097 | zinc finger, DHHC-type containing 21 (EC:2.3.1.225) |
C00002725
|
79973 | ZNF442 | zinc finger protein 442 |
C00002725
|
440515 | ZNF506 | zinc finger protein 506 |
C00002725
|
51193 | ZNF639, 6230400O18Rik, ANC-2H01, ANC_2H01, ZASC1 | zinc finger protein 639 |
C00002725
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00030830
|
1386 | ATF2, CRE-BP1, CREB2, HB16, TREB7 | activating transcription factor 2 (EC:2.3.1.48) |
C00003047
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00003047
|
1028 | CDKN1C, BWCR, BWS, KIP2, WBS, p57, p57Kip2 | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
C00003047
|
1030 | CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
C00003047
|
1447 | CSN2, CASB | casein beta |
C00003047
|
1509 | CTSD, CLN10, CPSD | cathepsin D (EC:3.4.23.5) |
C00003047
|
8745 | ADAM23, MDC-3, MDC3 | ADAM metallopeptidase domain 23 |
C00002725
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00003047
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00003047
|
1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00003047
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00003047
|
3297 | HSF1, HSTF1 | heat shock transcription factor 1 |
C00003047
|
3320 | HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
C00003047
|
3308 | HSPA4, APG-2, HS24/P52, HSPH2, RY, hsp70, hsp70RY | heat shock 70kDa protein 4 |
C00003047
|
3316 | HSPB2, HSP27, Hs.78846, LOH11CR1K, MKBP | heat shock 27kDa protein 2 |
C00003047
|
3398 | ID2, GIG8, ID2A, ID2H, bHLHb26 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
C00003047
|
8850 | KAT2B, CAF, P, P/CAF, PCAF | K(lysine) acetyltransferase 2B (EC:2.3.1.48) |
C00003047
|
100124292 |
C00003047
|
||
145447 | ABHD12B, BEM46L3, C14orf29, c14_5314 | abhydrolase domain containing 12B |
C00002725
|
7471 | WNT1, BMND16, INT1, OI15 | wingless-type MMTV integration site family, member 1 |
C00003047
|
26118 | WSB1, SWIP1, WSB-1 | WD repeat and SOCS box containing 1 |
C00003047
|
1135 | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) |
C00035784
|
1143 | CHRNB4 | cholinergic receptor, nicotinic, beta 4 (neuronal) |
C00035784
|
8714 | ABCC3, ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
C00002725
|
501 | ALDH7A1, ATQ1, EPD, PDE | aldehyde dehydrogenase 7 family, member A1 (EC:1.2.1.3 1.2.1.8 1.2.1.31) |
C00000357
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00001221
|
1579 | CYP4A11, CP4Y, CYP4A2, CYP4AII | cytochrome P450, family 4, subfamily A, polypeptide 11 (EC:1.14.15.3) |
C00001221
|
3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00000823
|
64127 | NOD2, ACUG, BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, NOD2B, PSORAS1 | nucleotide-binding oligomerization domain containing 2 |
C00001221
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002740
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002740
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00019221
|
9076 | CLDN1, CLD1, ILVASC, SEMP1 | claudin 1 |
C00001213
|
1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00003050
|
23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00003050
|
5906 | RAP1A, KREV-1, KREV1, RAP1, SMGP21 | RAP1A, member of RAS oncogene family |
C00003050
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00019221
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00000156
|
9131 | AIFM1, AIF, CMTX4, COWCK, COXPD6, PDCD8 | apoptosis-inducing factor, mitochondrion-associated, 1 |
C00000155
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000155
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000155
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000155
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000155
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000155
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00000155
|
9619 | ABCG1, ABC8, WHITE1 | ATP-binding cassette, sub-family G (WHITE), member 1 |
C00030479
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00019221
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00030479
|
1390 | CREM, CREM-2, ICER, hCREM-2 | cAMP responsive element modulator |
C00002725
|
1374 | CPT1A, CPT1, CPT1-L, L-CPT1 | carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21) |
C00030479
|
2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00030479
|
3034 | HAL, HIS, HSTD | histidine ammonia-lyase (EC:4.3.1.3) |
C00030479
|
57817 | HAMP, HEPC, HFE2B, LEAP1, PLTR | hepcidin antimicrobial peptide |
C00030479
|
3481 | IGF2, C11orf43, IGF-II, PP9974 | insulin-like growth factor 2 (somatomedin A) |
C00030479
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00030479
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00030479
|
4493 | MT1E, MT1, MTD | metallothionein 1E |
C00030479
|
4494 | MT1F, MT1 | metallothionein 1F |
C00030479
|
4496 | MT1H, MT-0, MT-1H, MT-IH, MT1 | metallothionein 1H |
C00030479
|
4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00030479
|
4502 | MT2A, MT2 | metallothionein 2A |
C00030479
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00030479
|
3651 | PDX1, GSF, IDX-1, IPF1, IUF1, MODY4, PDX-1, STF-1 | pancreatic and duodenal homeobox 1 |
C00030479
|
29893 | PSMC3IP, GT198, HOP2, HUMGT198A, ODG3, TBPIP | PSMC3 interacting protein |
C00030479
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00030479
|
23216 | TBC1D1, TBC, TBC1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
C00030479
|
7351 | UCP2, BMIQ4, SLC25A8, UCPH | uncoupling protein 2 (mitochondrial, proton carrier) |
C00030479
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00037855
|
847 | CAT | catalase (EC:1.11.1.6) |
C00037855
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00037855
|
1230 | CCR1, CD191, CKR-1, CKR1, CMKBR1, HM145, MIP1aR, SCYAR1 | chemokine (C-C motif) receptor 1 |
C00037855
|
2052 | EPHX1, EPHX, EPOX, HYL1, MEH | epoxide hydrolase 1, microsomal (xenobiotic) (EC:3.3.2.9) |
C00037855
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00037855
|
2952 | GSTT1 | glutathione S-transferase theta 1 (EC:2.5.1.18) |
C00037855
|
3303 | HSPA1A, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1 | heat shock 70kDa protein 1A |
C00037855
|
3937 | LCP2, SLP-76, SLP76 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
C00037855
|
4968 | OGG1, HMMH, HOGG1, MUTM, OGH1 | 8-oxoguanine DNA glycosylase (EC:4.2.99.18) |
C00037855
|
5894 | RAF1, CRAF, NS5, Raf-1, c-Raf | v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) |
C00037855
|
7042 | TGFB2, LDS4, TGF-beta2 | transforming growth factor, beta 2 |
C00037855
|
7049 | TGFBR3, BGCAN, betaglycan | transforming growth factor, beta receptor III |
C00037855
|
7515 | XRCC1, RCC | X-ray repair complementing defective repair in Chinese hamster cells 1 |
C00037855
|
7517 | XRCC3, CMM6 | X-ray repair complementing defective repair in Chinese hamster cells 3 |
C00037855
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P18054
P84022 |
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615040 | Episodic pain syndrome, familial, 1; feps1 |
O75762
|
#133239 | Esophageal cancer |
P04637
P18054 |
#615363 | Estrogen resistance; estrr |
P03372
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#245590 | Growth hormone insensitivity with immunodeficiency |
P51692
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#246300 | Leprosy, susceptibility to, 3; lprs3 |
O60603
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#267430 | Renal tubular dysgenesis; rtd |
P30556
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00344 | Leprosy |
O60603
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H00575 | Renal tubular dysgenesis |
P30556
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00931 | Growth hormone insensitivity with immunodeficiency |
P51692
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
Q13148
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D003877 | Dermatitis, Contact |
C00000805
C00019221 C00035062 C00000823 |
D012640 | Seizures |
C00035062
C00034452 |
D010146 | Pain |
C00002725
C00000156 |
D008114 | Liver Neoplasms, Experimental |
C00002740
C00000823 |
D006528 | Carcinoma, Hepatocellular |
C00002740
C00002725 |
D006984 | Hypertrophy |
C00002725
|
D008113 | Liver Neoplasms |
C00002740
|
D001919 | Bradycardia |
C00002740
|
D007674 | Kidney Diseases |
C00000823
|
D008107 | Liver Diseases |
C00000823
|
D008569 | Memory Disorders |
C00000823
|
D013276 | Stomach Ulcer |
C00000823
|
D009336 | Necrosis |
C00030828
|
D002471 | Cell Transformation, Neoplastic |
C00002725
|
D003110 | Colonic Neoplasms |
C00002725
|
D003371 | Cough |
C00002725
|
D003384 | Coxsackievirus Infections |
C00002725
|
D017449 | Dermatitis, Allergic Contact |
C00002725
|
D003921 | Diabetes Mellitus, Experimental |
C00002725
|
D003924 | Diabetes Mellitus, Type 2 |
C00002725
|
D004487 | Edema |
C00002725
|
D004890 | Erythema |
C00002725
|
D006470 | Hemorrhage |
C00002725
|
D006930 | Hyperalgesia |
C00002725
|
D006943 | Hyperglycemia |
C00002725
|
D007022 | Hypotension |
C00002740
|
D008545 | Melanoma |
C00002725
|
D012532 | Scabies |
C00019221
|
D011655 | Pulmonary Embolism |
C00002725
|
D012478 | Salmonella Food Poisoning |
C00002725
|
D012481 | Salmonella Infections, Animal |
C00002725
|
D012678 | Sensation Disorders |
C00002725
|
D013927 | Thrombosis |
C00002725
|
D014581 | Urticaria |
C00002725
|
D014735 | Vibrio Infections |
C00002725
|
D017453 | Dermatitis, Irritant |
C00003047
|
D006937 | Hypercholesterolemia |
C00003047
|
D007938 | Leukemia |
C00003047
|
D009369 | Neoplasms |
C00003047
|
D003128 | COMA |
C00001231
|
D003866 | Depressive Disorder |
C00000156
|
D003072 | Cognition Disorders |
C00030479
|
D001943 | Breast Neoplasms |
C00037855
|
D056486 | Drug-Induced Liver Injury |
C00037855
|
D005119 | Extravasation of Diagnostic and Therapeutic Materials |
C00037855
|
D034381 | Hearing Loss |
C00037855
|
D055370 | Lung Injury |
C00037855
|
D008175 | Lung Neoplasms |
C00037855
|
D015674 | Mammary Neoplasms, Animal |
C00037855
|
D011014 | Pneumonia |
C00037855
|
D011041 | Poisoning |
C00037855
|